
The quickly evolving development of biopharmaceuticals is impacting innovation in the industry overall.

The quickly evolving development of biopharmaceuticals is impacting innovation in the industry overall.

Unique surface properties and ligand functionalization provide real advantages.

Smart technologies, such as digital and laser printing, incorporated into manufacturing equipment are helping manufacturers align with sustainability goals, according to Sheikh Akbar Ali, general manager and head of Development and Technology for ACG Packaging Materials.

ICH Q6B provides expectations and a clear framework for the structural characterization of biopharmaceutical products.

Trends in certain forms of drug delivery, as well as the emergence of artificial intelligence, are playing roles in evolving the nature of partnerships, but there are new types of partnerships gaining steam as well.

Matt Cushing, VP of Quality and Science, Nelson Labs, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs Company, discuss PDA/ANSI Standard 06-2025: Assessment of Quality Culture Guidance Documents, Models, and Tools, which was published in February 2025.

Scientific breakthroughs, operational innovation, and cultural shifts are driving tomorrow’s medicines.